Immune and Cholestatic Liver Disease at the EASL Congress 2026
THIS YEAR, at the European Association for the Study of the Liver (EASL) Congress, there were exciting new developments... The post Immune and Cholestatic Liver Disease at the EASL Congress 2026…
Read the full articleYou might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Pooled analysis of over 120 clinical trials finds no increased cardiovascular risk with sildenafil (Viagra)
pubmed.ncbi.nlm.nih.gov·18m agoThe future of US psychedelic medicine is carved out by the FDA
refractor.io·25m ago
FDA approves first-of-its-kind cholesterol pill
masslive·3h ago
STAT+: Fresh turmoil roils American Diabetes Association following controversy at conference
STAT·3h ago
Lab study finds sweetener isosteviol slows growth of key gut bacteria, especially when combined with antidepressant
the-microbiologist.com·3h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.